Comprehensive Process Workflow for Personalized Cancer Vaccines

This white paper outlines the comprehensive process workflow necessary for the commercial use of personalized cancer vaccines. It discusses the increasing expectations for personalized cancer therapies, particularly personalized neoantigen cancer vaccine therapy, which is gaining attention as a significant advancement in cancer treatment. The document emphasizes the critical role of AI technology in identifying cancer-specific neoantigens and the importance of a sophisticated blend of AI and Information and Communication Technology (ICT) capabilities in developing personalized vaccines. The paper details various enablers required for this workflow, including securing traceability, genome data acquisition, and quality assurance. It also highlights the necessity of digitalization and robust data management to address challenges associated with large-scale adoption of personalized therapies. The white paper concludes by acknowledging the complex nature of the process workflow and the need for collaboration with ICT companies to realize the vision of effective personalized cancer vaccine therapies.